ClinicalTrials.Veeva

Menu

The Surveillance of Hepatocellular Carcinoma

C

Chinese PLA General Hospital (301 Hospital)

Status

Unknown

Conditions

Hepatocellular Carcinoma

Treatments

Other: Imaging examination and/or blood test

Study type

Observational

Funder types

Other

Identifiers

NCT05286099
S2022-001

Details and patient eligibility

About

Early detection of hepatocellular carcinoma is vita to the prognosis of patient. In this study, the occurrence and development of liver cancer were supervised by imaging examination, and the dysplastic nodules will be distinguished from early hepatocellular carcinoma through macro-imaging and micro-pathological features.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with Hepatitis B and cirrhosis Accept regular imaging examination. Pathological diagnosis of liver cancer.

Exclusion criteria

  • Can't tolerate the enhanced imaging examination Poor medical compliance

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems